6-amino-N-(2-((S)-2-(N-(2-aminoethyl)-3-mercaptopropanamido)-5-guanidinopentanamido)ethyl)-N-((S)-1-(2-(N-((S)-1,6-diamino-1-oxohexan-2-yl)-5-guanidinopentanamido)ethylamino)-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl)hexanamide

ID: ALA4560084

Chembl Id: CHEMBL4560084

PubChem CID: 155543434

Max Phase: Preclinical

Molecular Formula: C39H75N17O6S

Molecular Weight: 910.21

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)NCCCCC(=O)N(CCNC(=O)[C@H](Cc1c[nH]cn1)N(CCNC(=O)[C@H](CCCNC(=N)N)N(CCN)C(=O)CCS)C(=O)CCCCCN)[C@@H](CCCCN)C(N)=O

Standard InChI:  InChI=1S/C39H75N17O6S/c40-14-5-1-2-11-33(58)56(23-20-49-36(61)30(10-8-18-52-39(46)47)54(21-16-42)34(59)13-24-63)31(25-28-26-48-27-53-28)37(62)50-19-22-55(29(35(43)60)9-3-6-15-41)32(57)12-4-7-17-51-38(44)45/h26-27,29-31,63H,1-25,40-42H2,(H2,43,60)(H,48,53)(H,49,61)(H,50,62)(H4,44,45,51)(H4,46,47,52)/t29-,30-,31-/m0/s1

Standard InChI Key:  WNSYGDVXFUPAQZ-CHQNGUEUSA-N

Alternative Forms

  1. Parent:

    ALA4560084

    ---

Associated Targets(Human)

FAS Tbio Tumor necrosis factor receptor superfamily member 6 (11 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 910.21Molecular Weight (Monoisotopic): 909.5807AlogP: -2.90#Rotatable Bonds: 36
Polar Surface Area: 392.76Molecular Species: BASEHBA: 13HBD: 14
#RO5 Violations: 3HBA (Lipinski): 23HBD (Lipinski): 19#RO5 Violations (Lipinski): 3
CX Acidic pKa: 10.10CX Basic pKa: 13.15CX LogP: -5.00CX LogD: -16.33
Aromatic Rings: 1Heavy Atoms: 63QED Weighted: 0.01Np Likeness Score: -0.14

References

1. Nguyen HT, Guégan JP, Best D, van de Weghe P, Levoin N, Legembre P, Jean M..  (2019)  Probing the side chain tolerance for inhibitors of the CD95/PLCγ1 interaction.,  29  (21): [PMID:31526605] [10.1016/j.bmcl.2019.126669]
2. Nguyen HT, Guégan JP, Poissonnier A, Jouan F, Best D, van de Weghe P, Vacher P, Levoin N, Legembre P, Jean M..  (2019)  Synthesis of peptidomimetics and chemo-biological tools for CD95/PLCγ1 interaction analysis.,  29  (16): [PMID:31301931] [10.1016/j.bmcl.2019.07.006]

Source